Influence of artefact correction and recording device type on the practical application of a non-linear heart rate variability biomarker for aerobic threshold determination by Rogers B et al.
sensors
Article
Influence of Artefact Correction and Recording Device Type on
the Practical Application of a Non-Linear Heart Rate Variability
Biomarker for Aerobic Threshold Determination
Bruce Rogers 1,* , David Giles 2 , Nick Draper 3, Laurent Mourot 4,5 and Thomas Gronwald 6


Citation: Rogers, B.; Giles, D.;
Draper, N.; Mourot, L.; Gronwald, T.
Influence of Artefact Correction and
Recording Device Type on the
Practical Application of a Non-Linear
Heart Rate Variability Biomarker for
Aerobic Threshold Determination.
Sensors 2021, 21, 821. https://
doi.org/10.3390/s21030821
Academic Editor: Marco Altini
Received: 19 December 2020
Accepted: 22 January 2021
Published: 26 January 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 College of Medicine, University of Central Florida, 6850 Lake Nona Boulevard, Orlando, FL 32827-7408, USA
2 Lattice Training Ltd., Chesterfield S41 9AT, UK; dave@latticetraining.com
3 School of Health Sciences, College of Education, Health and Human Development, University of Canterbury,
Christchurch 8041, New Zealand; nick.draper@canterbury.ac.nz
4 EA3920 Prognostic Factors and Regulatory Factors of Cardiac and Vascular Pathologies, Exercise Performance
Health Innovation (EPHI) Platform, University of Bourgogne Franche-Comté, 25000 Besançon, France;
laurent.mourot@univ-fcomte.fr
5 Division for Physical Education, National Research Tomsk Polytechnic University,
Lenin Ave, 30, 634050 Tomsk Oblast, Russia
6 Department of Performance, Neuroscience, Therapy and Health, MSH Medical School Hamburg,
Faculty of Health Sciences, University of Applied Sciences and Medical University,
Am Kaiserkai 1, 20457 Hamburg, Germany; thomas.gronwald@medicalschool-hamburg.de
* Correspondence: bjrmd@knights.ucf.edu
Abstract: Recent study points to the value of a non-linear heart rate variability (HRV) biomarker using
detrended fluctuation analysis (DFA a1) for aerobic threshold determination (HRVT). Significance
of recording artefact, correction methods and device bias on DFA a1 during exercise and HRVT is
unclear. Gas exchange and HRV data were obtained from 17 participants during an incremental
treadmill run using both ECG and Polar H7 as recording devices. First, artefacts were randomly
placed in the ECG time series to equal 1, 3 and 6% missed beats with correction by Kubios software’s
automatic and medium threshold method. Based on linear regression, Bland Altman analysis and
Wilcoxon paired testing, there was bias present with increasing artefact quantity. Regardless of
artefact correction method, 1 to 3% missed beat artefact introduced small but discernible bias in
raw DFA a1 measurements. At 6% artefact using medium correction, proportional bias was found
(maximum 19%). Despite this bias, the mean HRVT determination was within 1 bpm across all
artefact levels and correction modalities. Second, the HRVT ascertained from synchronous ECG vs.
Polar H7 recordings did show an average bias of minus 4 bpm. Polar H7 results suggest that device
related bias is possible but in the reverse direction as artefact related bias.
Keywords: heart rate variability; detrended fluctuation analysis; ventilatory threshold; aerobic
threshold; intensity distribution; artefact; endurance exercise; heart rate monitors; wearables
1. Introduction
Several heart rate variability (HRV) indexes have shown potential as indicators of
exercise effort and training intensity zone demarcation [1,2]. Recently, a non-linear HRV
index of fractal correlation properties, the short-term scaling exponent alpha 1 of detrended
fluctuation analysis (DFA a1) has received particular attention as both an indicator of auto-
nomic nervous system regulation as well as an overall marker of organismic demand [3].
This measurement is based on fractal dynamics and self-similarity of the cardiac beat to
beat pattern [4]. DFA a1 has been shown to decline as work rates rise, starting from strongly
correlated patterns at levels below the first ventilatory threshold, transitioning through
values representing uncorrelated, less complex behavior at moderate to high work rates,
then finally showing anticorrelated and random patterns at the highest intensities [3,5,6].
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Recent work indicates that when exercise intensity reaches the first ventilatory threshold
during an incremental treadmill ramp protocol, DFA a1 values reach 0.75, corresponding
to the midway between well correlated fractal beat patterns (between order and disorder)
and those of uncorrelated behavior [7]. Since this study utilized interbeat data recorded by a
research grade ECG with little to no artefact, it is unclear if these results would be applicable
with higher artefact presence as well as using a typical chest belt recording device. In view of
the prospect of using a heart rate variability threshold (HRVT) derived from DFA a1 behavior
during an incremental exercise ramp for training intensity distribution, an expansion of this
concept with consumer wearable devices would be helpful.
The two most obvious issues that could alter the validity and reproducibility of the
HRVT from the laboratory to common practice are the possibility of bias induced by artefact
presence with correction and that of an alternate recording device. If the DFA a1 index is to
be a robust marker for intensity zone demarcation, consistency of measurement standards
is essential for both comparing the basic research done as well as for athletes and patients
using this for exercise and training monitoring. The typical method of recording the cardiac
interbeat interval in many settings will be via a chest belt device such as the Polar H series
(Polar Electro Oy, Kempele, Finland). Chest belt recording systems have been shown to
accurately measure heart rate during dynamic exercise [8] but the accuracy of HRV indexes
while using these devices can be variable [9–15]. Therefore, to support the usage of a DFA
a1 based HRVT for general application, the effects of artefact as well as a comparison to a
consumer chest belt device is necessary.
Artefacts are commonly present in many RR recording sessions and may be more nu-
merous during dynamic exercise at higher intensities when chest movements are involved,
i.e., typically running [11]. This may be due to intrinsic heart rate irregularities, false
beats related to spurious noise and missed beats due to erratic chest belt contact. Missed
beat artefacts have been shown to be the most common variety seen during dynamic
exercise [11]. In order for HRV analysis software to calculate the various time domain,
frequency domain and non-linear indexes, artefact correction algorithms have been de-
vised [16]. If artefact correction is not applied, even a single artefact can significantly alter
HRV parameters for a short measurement window [17,18]. Study results are mixed with
respect to the effects that correction methods have on HRV index accuracy when compared
to a parallel ECG recording without artefact [11,19–21]. Artefact correction algorithms gen-
erally encompass two separate actions. The initial step is identification of what comprises a
missed or aberrant beat, based on an approximation of the running pattern of the interbeat
interval. In the case of a missed beat, the next action is placing an artificial beat into the
gap in the RR series depending on a predetermined formula. This formula is based on
various interpolation models (e.g., linear, cubic spline) of the past and future RR series [16].
Potential deviation from the true position of the missed beat can be due to inappropriate
designation of aberrancy and/or failure to correctly model the interpolation.
A popular HRV software package, Kubios HRV Software (Version 3.4.1, Biosignal
Analysis and Medical Imaging Group, Kuopio, Finland) has two methods of artefact
correction. The freely available version of Kubios employs a cubic spline interpolation
method [22] that is termed “Threshold” correction. The “Threshold” level (Very Low, Low,
Medium, Strong, Very Strong or Custom) is based on the time deviation from an anticipated
beat pattern derived from a running average of the prior RR intervals. Depending on
the time difference from this average, the proposed aberrant beats are corrected by a
cubic spline formula. The “Premium” version of Kubios can employ this method but is
also capable of a newer correction technique called “Automatic” [23]. The “Automatic”
method uses a different modeling approach to determine beat aberrancy (without the
ability to adjust beat to beat time deviation tolerance). In addition, it appears to use linear
interpolation to replace the missing interval, inserting a replacement beat at the halfway
time point between the valid RR intervals. Thus, two different correction methods are
potentially available. Since the newer, “Automatic” method has only recently become
available, many previous investigations into artefact correction have not evaluated what,
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if any consequence is introduced by this process. Giles and Draper [11] have shown
significant bias in both non-linear and time domain HRV indexes with the “threshold”
artefact correction method of Kubios (Version 2.1). Other studies using various models
of either artificially inserted artefact [19,20] and animal models [21] have shown variable
effects on non-linear indexes. Some investigations have concluded that artefact correction
methods yielded similar index values but did not simultaneously record an artefact free
comparator and have just compared artefact correction methods to themselves [24]. Given
the interest of DFA a1 as an exercise intensity marker, it would be essential to know whether
artefact impacts the DFA a1 index and at what rates do the measurements lose validity.
Perhaps more importantly, what are the physiologic correlates of artefact presence and
correction methodology during dynamic exercise? Since this index declines with increasing
exercise intensity [3,25–29], does the presence of artefact and subsequent correction alter
the DFA a1 vs. intensity relationship?
Consequently, the purpose of this study was threefold:
1. Investigate the degree of bias in the DFA a1 index caused by the presence of missed
beat artefact by the automatic and threshold correction modalities of Kubios (Version
3.4.1). Since research groups and consumers will use this popular HRV software
program but only the threshold method is available in the free version, both artefact
correction methods will be examined.
2. To explore the importance of missed beat artefact on the location of the HRVT. In
other words, as a physiologic marker related to the aerobic threshold [6,7], does the
calculated HRVT heart rate shift by the presence of artefact?
3. Compare DFA a1 data gathered from a research grade ECG to that obtained from a
Polar H7 recording device. Although a direct comparison of artefact free tracings
from both a chest belt and ECG are easily accomplished for subjects at rest, it is
generally impractical to expect artefact free chest belt recording during high intensity
exercise [11]. In lieu of this limitation, we will not attempt to systematically compare
artefact free segments of Polar H7 vs. ECG data. Instead, a realistic use case compari-




Seventeen male volunteers aged 19 to 52, without previous medical history, current
medications or physical issues were tested. Participants were informed of the potential
testing risks and institutionally approved consent was given. Approval for the study was
granted by the University of Derby, UK [LSREC_1415_02] and conformed to the principles
of the Declaration of Helsinki. Participants did not consume caffeine, alcohol or any
stimulant for the 24 h before testing, nor was there any current tobacco usage. Background
data for each participant included, age (29 ± 10 y), body weight (77 ± 9 Kg) and training
volume in hours per week has been described [7]. All testing was done in the afternoon and
at least 3 h post meal. No exercise was performed the day prior to the test. Two participants
with excessive cardiac ectopy (frequent atrial premature beats and atrial trigeminy) during
testing were excluded from HRVT analysis.
2.2. Exercise Protocol
Participants performed an incremental maximal cardiopulmonary exercise test on a
motorized treadmill (Woodway, Birmingham, UK). The treadmill was set for the Bruce
protocol with increases in speed and inclination from 2.7 km/h at ten percent grade,
increasing by 1.3 km/h and two percent grade every 3 min until volitional exhaustion. A
fan was used for cooling.
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2.3. Gas Exchange Testing and Calculation of the First Ventilatory Threshold
Gas exchange kinetics were recorded continuously using a breath-to-breath metabolic
cart (Metalyzer 3B; Cortex Biophysik GmbH, Leipzig, Germany). In addition, a Polar H7
(Polar Electro Oy, Kempele, Finland) was wirelessly paired to the Metalyzer cart for the
purpose of beat to beat HR recording concurrent with gas exchange data. Analysis of the
above parameters were done to derive the first ventilator threshold (VT1), maximal oxygen
uptake (VO2MAX) and VO2 vs. time as previously reported and documented [7]. VT1 was
determined by the excess CO2 method [30]. Two experienced observers confirmed VT1
results independently.
2.4. RR Measurements and Calculation of DFA a1 Derived Threshold
A 3-lead ECG (MP36; Biopac Systems Ltd., Essen, Germany) with a sampling rate
of 1000 Hz was used to record the participant’s ECG/RR times series. Electrodes were
placed in the CM5 distribution after appropriate skin cleansing and shaving if necessary.
Sample data from the MP36 was saved as acq files. In addition, simultaneous record-
ing with the Polar H7 (Polar Electro Oy, Kempele, Finland) chest belt was done. ECG
and Polar H7 data files for each participant were imported into Kubios HRV Software
(Version 3.4.1, Biosignal Analysis and Medical Imaging Group, Department of Physics,
University of Kuopio, Kuopio, Finland). Kubios preprocessing settings were at the de-
fault values including the RR detrending method which was kept at “Smoothn priors”
(Lambda = 500 [22]). For DFA a1 estimation, the root mean square fluctuation of the inte-
grated and detrended data is measured in observation windows of different sizes. The data
are then plotted against the size of the window on a log-log scale. The scaling exponent
represents the slope of the line, which relates (log) fluctuation to (log) window size [6].
DFA a1 window width was set to 4 ≤ n ≤ 16 beats.
2.5. Artefact Addition to ECG and Influence on DFA a1
Each participant’s incremental ramp ECG was examined with Kubios software in-
cluding visual inspection to determine sample quality, noise, arrythmia and missing beat
artefact. Non-overlapping, consecutive, non-artefact containing 2-min measurement win-
dows were identified for each participant over their entire ramp. The chosen method of
artefact introduction is based on that used by Stapelberg et al. [20], which relies on manually
removing random beats from the already recorded artefact free series to achieve a desired
“missed beat” artefact percentage. A major advantage of this method is the elimination of
timing synchronization errors between paired comparisons as the same data windows are
evaluated. Since we are also interested in possible recording device differences, a cut beat
approach would eliminate any potential across device bias as well. Using the Kubios RR
editing tool (Premium Version), random RR peaks were removed from the measurement
windows to result in 1, 3 and 6% total missed beats per window. The HRV data were saved
as text files for baseline (no artefact, NA) each artefact manipulation step and correction
method applied, 1% induced artefact with automatic correction (1% AC), 1% induced
artefact with medium threshold correction (1% MC), 3% induced artefact with automatic
correction (3% AC), 3% induced artefact with medium threshold correction (3% MC), 6%
induced artefact with automatic correction (6% AC) and 6% induced artefact with medium
threshold correction (6% MC). The “medium” setting for the threshold correction method
was chosen based on it being the Kubios default choice as well as evidence of it being
optimal for adult populations [31].
2.6. Influence of Artefact on ECG Derived HRVT
A time varying data file was generated for each participant based on a 2-min measur-
ing window with a recalculation (grid interval) every 5 s throughout the test. As discussed
previously [7], a DFA a1 value of 0.75 was chosen for the detection of a HRV derived
threshold (HRVT) based on this being the midpoint between a fractal behavior of the HR
time series of 1.0 (seen with very light exercise) and an uncorrelated value of 0.5 which rep-
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resents uncorrelated/random behavior (seen with high intensity exercise). The following
procedure was used to indicate at what level of running intensity (represented by heart
rate) the DFA a1 would cross a value of 0.75: First, ECG data from each 2-min rolling
window was used to plot the average HR vs. DFA a1. The HR at which DFA a1 equaled
0.75 was found using a linear regression through the rapid change section of DFA a1 values
of about 1.0 to 0.5 or below, with a subsequent equation for HR and DFA a1. Using a fixed
variable of DFA a1 equals 0.75, the resulting HR was obtained from the equation. Only
10 participants with zero artefact in the HRVT measurement portion qualified for evalua-
tion in the artefact intervention comparison. This was done by repeating the HRVT process
for each artefact level and correction modality. The beginning and end time of the linear
regression was exactly matched for each participant over each artefact intervention.
2.7. Influence of Polar H7 on HRVT
All participants had Polar H7 recorded RR series analysis by Kubios software. HRVT
and artefact percentage was determined using the above-mentioned technique. To achieve
a sufficient sample size for meaningful comparison, the following limits to artefact were set
for study inclusion. Both the Polar and ECG derived data contained less than 5% artefact
during all 2-min HRVT related windows, which yielded 11 participants who met these
criteria. A summary of each inclusion criteria is shown in Figure 1.
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Figure 1. Inclusion criteria, numbers of included participants and data intervals for the threefold
purpose of this study.
2.8. Statistics
Statistical analysis was performed for the tested variables using standard methods
for the calculation of means, medians and standard deviations (SD). Normal distribution
of data was checked by Shapiro-Wilk testing and visual inspection of data histograms.
The correlation between the non-overlapping 2-min segments (artefact containing data
against the DFA a1 NA), HRVT NA vs. HRVT artefact intervention and HRVT Polar H7
vs. HRVT ECG was assessed using Pearson’s r correlation coefficient, standard error of
estimate (SEE), coefficient of determination (R2) and Bland Altman plots with limits of
agreement [32]. The size of Pearson’s r correlations evaluated as follows; 0.3 ≤ r < 0.5
low; 0.6 ≤ r < 0.8 moderate and r ≥ 0.8 high [33]. Estimate of the median difference
between NA and artefact segments of the non-overlapping 2-min windows was calculated
using the Hod es Lehmann shift method along with Wilc xon testing of paired groups
in view of potential outlier values [34,35]. Although agreement between groups was
assessed by Bland Altman analysis, if proportional bias was detected, regression-based
calculation of mean differences and limits of agreement were performed [36,37]. Bland
Altman mean differences for 2-min segment comparisons was expressed as percentage
bias (difference/mean × 100). Conventional Bland Altman analysis was performed to
determine agreement between HRVT groups. Paired t testing was used for comparison of
HRVT for both artefact and device conditions. For all tests, the statistical significance was
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accepted as p ≤ 0.05. Cohen’s d was used to denote effect sizes (small effect = 0.2, medium
effect = 0.5, large effect = 0.8; [38]). Analysis was performed using Microsoft Excel 365 with
Real Statistics Resource Pack software (Release 6.8) and Analyse-it software (Version 5.66).
3. Results
3.1. Gas Exchange
Detailed gas exchange results and heart rate at HRVT has been previously reported
(7). Mean participant VO2MAX was 56 mL/kg/min (±10), VT1 was reached at 70% (±6) of
VO2MAX, heart rate at VT1 by gas exchange was 152 bpm (±21), HRVT heart rate 154 bpm
(±20) and artefact 0.6% (±0.9) during the HRVT relevant RR series.
3.2. Artefact Addition to ECG Recording and Influence on DFA a1with 1, 3 and 6% Artefact
There were 102 DFA a1 measurement windows from 16 participants that were free
of artefact. Table 1 contains the mean, standard deviation, median, minimum, maximum,
along with paired artefact group comparisons to DFA a1 NA including adjusted Hodges
Lehmann median shift, Wilcoxon paired testing and Pearson’s r. Regression plots for DFA
a1 NA vs. each artefact condition and correction method are shown in Figure 2. Correlation
values ranged from 0.999 to 0.980, with AC generally higher than MC for each artefact
group. Bland Altman difference charts were done for each condition (1, 3, 6% artefact AC
and MC) as seen in Figure 3. Analysis of proportional bias (change in the bias over the
DFA a1 range), heteroscedasticity (change in scatter of differences) was evaluated with
regression of either mean differences and/or limits of agreement respectively according to
the recommendations of Ludbrook [36].
Table 1. Two-minute measurement windows derived from ECG recordings for DFA a1 no artefact (NA) vs. artefact
containing (1, 3, 6%) data and correction method (automatic, AC, medium threshold, MC): Mean (±standard deviation, SD),
Median, Minimum, Maximum, adjusted median difference (AMD) from DFA a1 vs. NA according to Hodges Lehmann
method (p-value estimated by Wilcoxon paired testing), coefficient of determination (R2), Pearson’s r and Standard Estimate
of Error (SEE) from paired data of DFA a1 NA vs. DFA a1 for each artefact condition and correction method.
























Median 1.0251 1.0267 1.03385 1.0315 1.01605 1.014 1.02955
Maximum 1.5995 1.5986 1.6567 1.6039 1.6566 1.6041 1.633
Minimum 0.2171 0.2212 0.2402 0.2281 0.291 0.2208 0.3202











R2 (vs. NA) 0.999 0.977 0.997 0.960 0.983 0.962
Pearson’s r
(vs. NA) 0.999 0.989 0.998 0.980 0.991 0.981
SEE 0.013 0.059 0.023 0.079 0.052 0.072
3.3. Influence of Artefact Condition and Correction Method on the ECG Derived HRVT
The impact of artefact condition and correction method on the calculated, ECG derived
HRVT for each participant is shown in Table 2. Although small differences in mean HRVT
were seen between artefact groups and NA, only the 6% AC group reached significance on
t testing. Bland Altman difference analysis is shown in Figure 4. Artefact levels of 1, 3 and
6% caused an average bias of 0.1, 0.4 and 1.3 bpm using AC and 0.3, 0.3 and 1.2 bpm using
MC method. Limits of agreement for the three groups were −1 to 0.8, 1 to −1.9, 2.2 to
−4.7 bpm for AC and 0.6 to 1.2, 1.3 to 2.0 and 2.2 to −4.5 for MC respectively. All points
were within the 2 standard deviation limits of agreement.
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Figure 2. Regression plots for all ECG derived DFA a1 NA vs. DFA a1 for each artefact condition and correction method.
(A) vs. DFA a1 1% AC; (B) vs. DFA a1 1% MC; (C) vs. DFA a1 3% AC; (D) vs. DFA a1 3% MC; (E) vs. DFA a1 6% AC; (F) vs.
DFA a1 6% MC. Bisection lines in light gray. Slope and Pearson’s r shown in bottom right of each plot.
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Figure 3. Bland Altman analysis of ECG derived DFA a1 NA vs. DFA a1 for each artefact condition and correction method
using regression based mean and standard deviations. ( ) s. F a1 1 ; (B) vs. DFA a1 1% MC; (C) vs. DFA a1 3%
AC; (D) vs. DFA a1 3% MC; (E) vs. DFA a1 6% AC; ( ) vs. DFA a1 6% MC. Center solid line in each plot repr sents the
mean bias (diff rence) between each paired value as relative percent (differ nce/mean × 100). The top and bottom dashed
lines are 1.96 standard deviations from the mean difference. Pearson’s r for the regression line of bias with p value shown
on top right of each plot.
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Table 2. Comparison of ECG derived heart rate at HRVT for 10 participants with no baseline artefact (NA), across each
artefact condition and correction method. Mean (±standard deviation, SD) in last row. * denotes p ≤ 0.05 on t testing HRVT
NA vs. HRVT for each artefact condition and correction method.
HRVT NA HRVT 1% AC HRVT 1% MC HRVT 3% AC HRVT 3% MC HRVT 6% AC HRVT 6% MC
155.2 155.3 156.1 156.6 155.9 159.8 156.3
185.2 185.4 185.7 185.9 184.6 186.0 184.7
125.9 126.3 125.7 125.9 125.3 126.5 124.3
137.5 137.9 137.9 137.7 137.6 138.3 137.9
137.4 137.5 138.1 137.5 138.3 137.5 138.7
162.6 163.0 163.0 163.2 164.2 163.3 165.0
175.4 175.0 176.3 175.8 176.7 175.7 179.0
133.8 134.7 133.3 135.6 134.3 138.2 137.6
170.6 170.2 170.5 170.4 169.7 171.1 171.2
174.6 174.0 174.7 173.9 175.0 174.3 175.0

















Figure 4. Bland Altman analysis of ECG derived HRVT NA vs. HRVT for each artefact condition and correction method. 
A: vs. 1% AC; B: vs. 1% MC; C: vs. 3% AC; D: vs. 3% MC; E: vs. 6% AC; F: vs. 6% MC. Center solid line in each plot 
represents the mean bias (difference) between each paired value. The top and bottom lines are 1.96 standard deviations 
from the mean difference. Net bias with standard deviation (SD) in top right portion of each plot with standard deviation 
(SD) in top right portion of each plot. 
3.4. HRVT Derived from ECG vs. HRVT Derived from Polar H7 
The HRVT derived from the Biopac 36 ECG was compared to that of the HRVT ob-
tained from Polar H7 data. Both times series contained less than 5% artefact during each 
2-min measurement window. The AC method was used for all RR time series based on 
the superior bias seen in comparison to MC. Results are presented in Table 3. Bland Alt-
man difference analysis is shown in Figure 5. There was a 4 bpm difference in the mean 
Figure 4. Bland Altman analysis of ECG deriv d HRVT NA vs RVT for each ar efact c ndition and correction method.
(A) vs. 1% AC; (B) vs. 1% MC; (C) vs. 3% AC; (D) vs. 3% MC; (E) vs. 6% AC; (F) vs. 6% MC. Center solid line in each plot
represents the mean bias (difference) between each paired value. The top and bottom lines are 1.96 standard deviations
from the mean difference. Ne bias with s andard deviation (SD) in top right portion of each plot with standard deviation
(SD) in top right portion of each plot.
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3.4. HRVT Derived from ECG vs. HRVT Derived from Polar H7
The HRVT derived from the Biopac 36 ECG was compared to that of the HRVT
obtained from Polar H7 data. Both times series contained less than 5% artefact during each
2-min measurement window. The AC method was used for all RR time series based on the
superior bias seen in comparison to MC. Results are presented in Table 3. Bland Altman
difference analysis is shown in Figure 5. There was a 4 bpm difference in the mean heart
rate between the ECG derived HRVT and the Polar H7 data series (p = 0.002, d = 0.228). The
bias between recording devices is best illustrated in one participant who had zero artefacts
in both the ECG and Polar sequence shown (Figure 6). In this individual’s RR recordings,
Pearson’s r correlation between time matched pairs of heart rate for the ECG vs. Polar H7
device heart rate was 0.999 with a slope of 1.0 confirming a near perfect synchronization
of the HRV sequence. Time varying display of DFA a1 showed a lower Polar H7 value
at almost every measurement window. It should also be noted that this subject had the
largest HRVT difference between devices. As will be discussed later, the bias seen here is
in the opposing direction from artefact correction as seen with the ECG based 6% MC.
Table 3. Comparison of heart rate at HRVT between ECG vs. Polar H7 data both using automatic
artefact correction (AC). Percent artefact for all data calculated over the HRVT measurement range
below 5%. Mean (±standard deviation, SD) in last row. * denotes p ≤ 0.05 on paired t testing.
















The purpose of this report was to explore three questions, does bias occurs in the
non-linear HRV index DFA a1 from missed beat artefact correction, is there an impact
of these artefacts (with correction) on the aerobic threshold related HRVT and does an
alternate recording device produce comparable HRVT results to a research grade ECG. The
importance of evaluating a physiologic biomarker, the HRVT revolves around the clinical
consequence of any noted bias. Even though some numerical bias may occur, it would be
important to ascribe a functional relevance to this by leveraging the relationship of DFA
a1 decline with increasing exercise intensity [3]. Prior HRV studies have generally not
attempted to associate the effect of artefact correction on the corresponding physiological
response of interest. It is likely that typical users interested in exercise monitoring will be
using a chest belt device with potential missed beat artefact in the recording. Therefore,
in view of our recent study linking a DFA a1 derived HRVT with the first ventilatory
threshold [7] an examination of both artefact and recording device bias is warranted before
extrapolating these results to real world consumer usage.
Sensors 2021, 21, 821 11 of 15
Sensors 2021, 21, x 11 of 16 
 
 
heart rate between the ECG derived HRVT and the Polar H7 data series (p = 0.002, d = 
0.228). The bias between recording devices is best illustrated in one participant who had 
zero artefacts in both the ECG and Polar sequence shown (Figure 6). In this individual’s 
RR recordings, Pearson’s r correlation between time matched pairs of heart rate for the 
ECG vs. Polar H7 device heart rate was 0.999 with a slope of 1.0 confirming a near perfect 
synchronization of the HRV sequence. Time varying display of DFA a1 showed a lower 
Polar H7 value at almost every measurement window. It should also be noted that this 
subject had the largest HRVT difference between devices. As will be discussed later, the 
bias seen here is in the opposing direction from artefact correction as seen with the ECG 
based 6% MC.  
Table 3. Comparison of heart rate at HRVT between ECG vs. Polar H7 data both using automatic 
artefact correction (AC). Percent artefact for all data calculated over the HRVT measurement range 
below 5%. Mean (±standard deviation, SD) in last row. * denotes p = ≤ 0.05 on paired t testing. 
 HRVT ECG AC HRVT Polar H7 AC 
 155.2 152.3 
 185.2 182.9 
 125.9 124.6 
 137.5 135.1 
 160.0 156.4 
 137.4 137.5 
 162.6 154.6 
 160.3 157.1 
 171.0 166.0 
 175.4 164.0 
 133.8 129.0 
Mean (±SD) 
154.9 bpm  
(±19.0) 
150.9 bpm*  
(±17.6) 
 
Figure 5. Comparison of heart rate at HRVT between ECG vs. Polar H7 data using Bland Altman analysis. The one outlier
(labeled as X) represents the only participant with no artefact in both ECG and Polar H7 time series. Center line represents
the mean bias (difference) between each paired value. The top and bottom lines are 1.96 standard deviation from the mean
difference. Bias and standard deviation (SD) listed in upper right corner.
Sensors 2021, 21, x 12 of 16 
 
 
Figure 5. Comparison of heart rate at HRVT between ECG vs. Polar H7 data using Bland Altman analysis. The one outlier 
(labeled as X) represents the only participant with no artefact in both ECG and Polar H7 time series. Center line represents 
the mean bias (difference) between each paired value. The top and bottom lines are 1.96 standard deviation from the mean 
difference. Bias and standard deviation (SD) listed in upper right corner. 
 
Figure 6. Time-varying analysis (window width: 120s, grid interval: 5s), DFA a1 for matched time 
series containing no artefact in one representative participant, ECG (solid triangle), Polar H7 (open 
circle), ECG 6% MC (open triangle). 
4. Discussion 
The purpose of this report was to explore three questions, does bias occurs in the 
non-linear HRV index DFA a1 from missed beat artefact correction, is there an impact of 
these artefacts (with correction) on the aerobic threshold related HRVT and does an alter-
nate recording device produce comparable HRVT results to a research grade ECG. The 
importance of evaluating a physiologic biomarker, the HRVT revolves around the clinical 
consequence of any noted bias. Even though some numerical bias may occur, it would be 
important to ascribe a functional relevance to this by leveraging the relationship of DFA 
a1 decline with increasing exercise intensity [3]. Prior HRV studies have generally not 
attempted to associate the effect of artefact correction on the corresponding physiological 
response of interest. It is likely that typical users interested in exercise monitoring will be 
using a chest belt device with potential missed beat artefact in the recording. Therefore, 
in view of our recent study linking a DFA a1 derived HRVT with the first ventilatory 
threshold [7] an examination of both artefact and recording device bias is warranted be-
fore extrapolating these results to real world consumer usage.  
Our results show that the artificial addition of between 1 and 6% missed beat artefact 
did induce progressive amounts of bias into the calculation of DFA a1. Using either the 
AC or MC methods from Kubios Software at the 1 or even 3% level produced similar 
results in the median DFA a1 index with small amounts of bias in the Bland Altman anal-
ysis. Even at the 6% level, AC methodology produced reasonable results, albeit with some 
proportional bias and more outliers. However, at 6% MC, both a large number of outliers 
and substantial proportional bias was seen. It should be noted that previous reports show-
ing high levels of bias in non-linear HRV during exercise used the medium threshold cor-
rection method [11]. As the level of artefact rose, AC methodology demonstrated both less 
bias as well as a reduction in scatter between the differences. Review of the regression 
Figure 6. Time-varying analysis (window width: 120 s, grid interval: 5 s), DFA a1 for matched time series containing no
artefact in one representative participant, ECG (solid triangle), Polar H7 (open circle), ECG 6% MC (open triangle).
Sensors 2021, 21, 821 12 of 15
Our results show that the artificial addition of between 1 and 6% missed beat artefact
did induce progressive amounts of bias into the calculation of DFA a1. Using either the AC
or MC methods from Kubios Software at the 1 or even 3% level produced similar results in
the median DFA a1 index with small amounts of bias in the Bland Altman analysis. Even at
the 6% level, AC methodology produced reasonable results, albeit with some proportional
bias and more outliers. However, at 6% MC, both a large number of outliers and substantial
proportional bias was seen. It should be noted that previous reports showing high levels of
bias in non-linear HRV during exercise used the medium threshold correction method [11].
As the level of artefact rose, AC methodology demonstrated both less bias as well as a
reduction in scatter between the differences. Review of the regression analysis for each
artefact level and correction method also confirms the trivial effects of 1% artefact especially
with AC usage. However, at higher artefact levels, artefact correction falsely raised the
DFA a1 index, particularly across its low, uncorrelated and anticorrelated range (interbeat
random behavior). Calculation of the HRVT was minimally affected by either 1 or 3%
artefact using either correction method. At the 6% artefact level, both AC and MC had
similar results, although with small degrees of bias reaching just over 1 bpm. It is interesting
to speculate why large amounts of the proportional bias seen with the 6% MC group, had
marginal effects on the HRVT. The HRVT is calculated for DFA a1 values between 1 and
0.5, however even with 6% artefact, values just under 1 are minimally affected, values near
0.5 moderately affected, with most of the bias below this point. After reviewing the Bland
Altman analysis for the 2-min window comparisons, one could conclude that the addition
of 3% missed beat artefact would have minimal, if any effect on the HRVT unless the index
was skewed by a random outlier value. At the 6% artefact level, one would also expect
reasonable concordance with artefact free data. However, there was a higher occurrence of
outliers, especially using MC which could indicate the need to repeat the HRVT assessment
for confirmation.
A surprising finding of this study was the discordance of DFA a1 measured by the
research grade ECG and that of the Polar H7 chest belt. Although the absolute bias
was about minus 4 bpm for the Polar H7 chest belt, this may not be of major clinical
relevance especially given the low effect size, however the limits of agreement were about
±6 bpm, corresponding to a net negative 10 bpm. Other studies looking at HRV validation
across devices similar to the Polar H7 have not reported similar findings [9,10,12–15].
Several reasons for this discrepancy are possible. Most device comparisons are done at
rest and not during dynamic exercise as was done here. One study using similar device
comparisons [16] did not perform detailed analysis of non-linear HRV over the spectrum of
exercise intensities. An interesting scenario that may help explain the lack of cross device
discrepancy reported in the literature may relate to the bias negation caused by artefact
correction effects. For example, at higher artefact levels, especially when corrected by
MC, the proportional bias leads to a higher than expected DFA a1 especially at the lower,
anticorrelated ranges below 0.5. Therefore, the downward bias in the Polar H7 recording
(especially in the uncorrelated range) would be somewhat offset by the effects of expected
artefact at higher intensity. This is best understood with the simultaneous measurement
of both heart rate and HRV in one specific case (Figure 6). This participant, who had
no artefact in both device recordings for a substantial length of time, clearly shows that
DFA a1 calculated from the Polar H7 RR time series was consistently lower than that of
ECG based results, especially at uncorrelated ranges. The parallel ECG recording with 6%
MC data series was included to show how a potential neutralization of bias could occur
with coexistent artefact. The negative bias of the Polar H7 would be counterbalanced by
the positive bias from artefact correction leading to DFA a1 values near the correct range.
Proper synchronization of this time series was corroborated by a plot of the heart rate
recorded by each device showing near perfect agreement and correlation.
Our results did show differences between correction methods (AC vs. MC) for DFA
a1 during the 2-min measurement window comparisons. Both methods use a somewhat
similar missing beat interpolation approach, namely cubic spline with “Threshold” or
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linear with “Automatic” correction. They do use different strategies for aberrant or missing
beat detection, which may have led to an advantage in AC. Regression analysis showed less
point scatter and Bland Altman plots showed less bias with narrower limits of agreement
with AC. However, outliers were still present with AC, making a potential erroneous result
possible. The question arises as to why conventional artefact correction modalities do not
appear to accurately reproduce this non-linear index especially with increasing artefact
levels. It may not be possible to correctly predict lost beat placement based on formulas that
do not consider the fractal, self-similar characteristics that DFA a1 is based on. Supporting
this concept is that with increasing levels of artefact correction, DFA a1 showed higher
values at uncorrelated level than at fractal and well correlated level. Past proposals for
replacing missed beats have explored non-linear methods [21,39] and may be reconsidered.
The underlying mechanism for the disparity between Polar H7 vs. ECG measurements is
also unclear but may revolve around methodology of the preprocessing algorithms used to
filter background noise and muscular contractile activity [40,41]. Since the DFA a1 index
reflects interbeat fractal correlation properties, subtle changes in measuring the R wave
peak could be responsible for the changes seen between recording devices [42].
5. Limitations and Future Directions
Although we chose the Kubios “Threshold” artefact correction option in the present
study as “Medium”, other RR timing prediction limits could have been utilized (Very Low,
Low, Strong, Very Strong). Recent data indicates that setting the “Threshold” to “Very
Strong” may cause an excessive degree of interpolation [31]. That report recommended
choosing any filter setting except “Very Strong” for adult data series analysis. Therefore,
the “Medium” setting may represent an optimal balance between sensing a true artefact as
opposed to mistakenly interpolating normal sinus variations. Sample size was relatively
small for both the artefact related and device comparisons. Due to the need for the
reference based HRV data to be free of artefact including atrial premature complexes
(APCs), future studies may need substantial numbers of participants to obtain arrythmia
free samples. Regarding direct device comparison, resting measurements were not done
to determine bias between the Polar H7 and ECG during that condition. It is certainly
possible that these bias results do not apply to resting data with high correlation, fractal
patterns. Although recording device sample rates have been proposed as a possible factor
in non-linear HRV bias [43], both the ECG and Polar H7 possess identical rates of 1000 Hz.
If further study does confirm device related bias in the DFA a1 at high intensity ranges,
adjustments in HRVT calculations may be necessary. In addition, modification of DFA
a1 targets for constant power exercise sessions may be needed. An exciting development
regarding chest belt recording revolves around that of artefact and arrhythmia identification.
Upcoming generations of chest belt devices will possess the capability to display the
ECG waveform, opening the possibility of proper correction of missed beats, noise and
arrhythmia identification [44].
6. Conclusions and Practical Implications
Three major findings were observed in this study. First, bias induced by missed beat
artefact correction depended on the correlation properties of the measured RR time series.
The highest level of bias occurred at uncorrelated and anticorrelated values of DFA a1
resulting in an upward shift in the index. At fractal to correlated levels (DFA a1 near or
above 1), minimal effects were seen. This is fortuitous since this range is present during
resting and minimal exercise intensity, situations commonly studied. However, as exercise
intensity rises and DFA a1 declines, artefact correction bias may substantially increase,
potentially causing a falsely high DFA a1 reading at uncorrelated levels. If one were
using this index to adjust training efforts based on power levels to avoid an uncorrelated
DFA a1, substantial artefact could lead to misleading intensity targets. Nevertheless,
despite the variable bias on the raw DFA a1 value, the HRVT determination did not
appear to suffer greatly at low to moderate artefact levels (1% to 3%). This should be
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reassuring to investigators, coaches and athletes interested in using the index behavior
either for aerobic threshold determination by means of an incremental ramp or internal load
assessment during constant power exercise intervals. The finding of a chest belt recording
device having a negative bias was unexpected. Studies using similar devices have shown
reasonable concordance with high quality ECG derived HRV parameters but have mainly
been compared at rest and/or contained some artefact in the RR series. In addition, there
is the possibility that the downward Polar H7 bias combined with the upward artefact
correction bias leads to values near the reference range. Given the suggestive but limited
data on device related bias during exercise, further comparative study is recommended.
In summary, levels of artefact correction commonly seen during exercise may cause some
bias in DFA a1 measurement but should not lead to invalidating its usage with exercise
threshold concepts.
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